Investor Presentaiton slide image

Investor Presentaiton

We have the right strategy at the right time to develop transformational medicines & change patients' lives Causal human biology Path to improve R&D productivity Use of human data for rigorous target validation in drug discovery Build on our strength in five core therapeutic areas • Matching modality to mechanism Diverse portfolio of modalities supplemented with Al and ML Diverse modalities, including Targeted Protein Degradation and Cell Therapy 88 Path to clinical proof-of-concept Enable mechanistic models for dose, schedule, and patient selection All enabled by translational insights, computational science and BD partnerships Ill Bristol Myers Squibb™ . Increase number of INDs with transformational potential Increase success in clinical development Not for Product Promotional Use 50
View entire presentation